303 related articles for article (PubMed ID: 35682731)
1. Challenges and Future of Drug-Induced Liver Injury Research-Laboratory Tests.
Weber S; Gerbes AL
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682731
[TBL] [Abstract][Full Text] [Related]
2. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
3. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
4. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
[TBL] [Abstract][Full Text] [Related]
5. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
[TBL] [Abstract][Full Text] [Related]
7. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
8. [Advances in clinical differentiation between immunological and drug-induced liver injury].
Wang Y; Li YN; Zhang J; Wang BM; Zhou L
Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):717-720. PubMed ID: 29108197
[TBL] [Abstract][Full Text] [Related]
9. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Histopathology of Drug-Induced Liver Injury.
Kleiner DE
Surg Pathol Clin; 2018 Jun; 11(2):297-311. PubMed ID: 29751876
[TBL] [Abstract][Full Text] [Related]
11. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.
Ju HY; Jang JY; Jeong SW; Woo SA; Kong MG; Jang HY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Jin SY; Kim HS; Kim BS
Clin Mol Hepatol; 2012 Jun; 18(2):213-8. PubMed ID: 22893872
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis.
Lewis JH
Nat Rev Gastroenterol Hepatol; 2011 Aug; 8(10):540-2. PubMed ID: 21862981
[No Abstract] [Full Text] [Related]
13. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Teschke R; Schulze J; Eickhoff A; Danan G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.
Cueto-Sánchez A; Niu H; Álvarez-Álvarez I; López-Longarela B; Del Campo-Herrera E; Ortega-Alonso A; García-Cortés M; Pinazo-Bandera J; Sanabria-Cabrera J; Díaz-Mochón JJ; Lucena MI; Andrade RJ; Stephens C; Robles-Díaz M
Br J Clin Pharmacol; 2023 Aug; 89(8):2497-2507. PubMed ID: 36965054
[TBL] [Abstract][Full Text] [Related]
15. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
[TBL] [Abstract][Full Text] [Related]
17. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
18. Case definition and phenotype standardization in drug-induced liver injury.
Aithal GP; Watkins PB; Andrade RJ; Larrey D; Molokhia M; Takikawa H; Hunt CM; Wilke RA; Avigan M; Kaplowitz N; Bjornsson E; Daly AK
Clin Pharmacol Ther; 2011 Jun; 89(6):806-15. PubMed ID: 21544079
[TBL] [Abstract][Full Text] [Related]
19. Two-step progression of varenicline-induced autoimmune hepatitis.
Sakakibara M; Ohkawa K; Nawa T; Abe Y; Kusakabe A; Imai T; Katayama K
Clin J Gastroenterol; 2018 Jun; 11(3):184-187. PubMed ID: 29383494
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome.
Hayashi M; Abe K; Imaizumi H; Okai K; Kanno Y; Takahashi A; Ohira H
Clin J Gastroenterol; 2016 Jun; 9(3):150-5. PubMed ID: 27076346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
